BAH vs CRL · P/E 10, rev $11.22B vs rev $2.00B
Booz Allen Hamilton Holding (BAH) versus Charles River Laboratories (CRL) — a side-by-side from cached financials, not a winner call.
Booz Allen Hamilton Holding (BAH) is a consulting services company listed on NYSE.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Latest reported BAH revenue for 2026-03-31 was $11.22B. Net income was $851.0M. Revenue was down 6.4% from 2025-03-31 to 2026-03-31. BAH currently screens at market cap $8.53B and trailing P/E 10.3.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
BAH currently screens at market cap $8.53B and trailing P/E 10.3. CRL currently screens at market cap $7.78B.
Not investment advice. Open the BAH and CRL stock pages for the full models.
Not investment advice.